Trimetazidine in conditions other than coronary disease, old drug, new tricks?
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.02.083
Abstract: Trimetazidine (TMZ) has traditionally been used as an anti-ischemic drug for coronary artery disease by selectively inhibiting the mitochondrial long-chain 3-ketoacyl-CoA thiolase. Recently, new applications for this therapy have been investigated. This article reviews alternative… read more here.
Keywords: trimetazidine conditions; conditions coronary; disease; drug ... See more keywords